VestGen Advisors LLC Acquires 14,400 Shares of iShares Biotechnology ETF $IBB

VestGen Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 296.9% during the third quarter, Holdings Channel reports. The firm owned 19,250 shares of the financial services provider’s stock after acquiring an additional 14,400 shares during the quarter. VestGen Advisors LLC’s holdings in iShares Biotechnology ETF were worth $4,053,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. William Mack & Associates Inc. acquired a new position in iShares Biotechnology ETF during the 3rd quarter valued at approximately $89,000. Willow Creek Wealth Management Inc. bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at about $204,000. MADDEN SECURITIES Corp acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $100,000. Latitude Advisors LLC bought a new stake in iShares Biotechnology ETF during the third quarter valued at about $84,000. Finally, Ashton Thomas Securities LLC acquired a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at approximately $550,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $217.86 on Friday. iShares Biotechnology ETF has a 12 month low of $154.62 and a 12 month high of $220.31. The firm has a fifty day simple moving average of $208.29 and a two-hundred day simple moving average of $184.58.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were paid a $0.0112 dividend. This is a drop from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. The ex-dividend date of this dividend was Tuesday, September 15th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.0%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.